NCT04005053View on ClinicalTrials.gov

Signatures of N-Ac for Non-Suicidal Self-Injury in Adolescents

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

May 8, 2022

Study Completion Date

October 1, 2022

Conditions
Self-HarmDepressionSuicide
Interventions
DRUG

N-acetyl cysteine

3600 or 5400 mg/day N-acetyl cysteine

DRUG

Placebo oral tablet

Placebo

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT04005053 - Signatures of N-Ac for Non-Suicidal Self-Injury in Adolescents | Biotech Hunter | Biotech Hunter